Ole Kirk

Ole Kirk

Postgraduate Clinical Associate Professor, Clinical Associate Professor

Member of:

  • Internal medicine: infection medicine


  1. 2017
  2. Published

    One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America

    Podlekareva, D., Schultze, A., Panteleev, A., Skrahina, A., Miro, J., Rakhmanova, A., Furrer, H., Miller, R., Efsen, A., Losso, M., Toibaro, J., Vassilenko, A., Girardi, E., Lundgren, Jens, Mocroft, A., Post, F., Kirk, Ole & TB:HIV Study writing Group, T. S. W. G., 2017, In: AIDS. 31, 3, p. 375-384

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Predictors of estimated glomerular filtration rate progression, stabilization or improvement after chronic renal impairment in HIV-positive individuals

    Ryom, L., Mocroft, A., Kirk, Ole, Reiss, P., Ross, M., Smith, C., Moranne, O., Morlat, P., Fux, C. A., Sabin, C., Phillips, A., Law, M., Lundgren, Jens & D:A:D Study Group, D. S. G., 2017, In: AIDS. 31, 9, p. 1261-1270

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. 2016
  5. Published

    Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia

    Rohner, E., Schmidlin, K., Zwahlen, M., Chakraborty, R., Clifford, G., Obel, N., Grabar, S., Verbon, A., Noguera-Julian, A., Judd, A., Collins, I. J., Rojo, P., Brockmeyer, N., Campbell, M., Chêne, G., Prozesky, H., Eley, B., Stefan, D. C., Davidson, A., Chimbetete, C. & 9 others, Sawry, S., Davies, M., Kariminia, A., Vibol, U., Sohn, A., Egger, M., Bohlius, J., Kirk, Ole & Pediatric AIDS-Defining Cancer Project Working Group for IeDEA Southern Africa, TApHOD, and COHERE in EuroCoord, P. A. C. P. W. G. F. I. S. A. T. A. C. I. E., 1 Nov 2016, In: Clinical Infectious Diseases. 63, 9, p. 1245-1253 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    The cardiovascular risk management for people living with HIV in Europe: how well are we doing?

    Shahmanesh, M., Schultze, A., Burns, F., Kirk, Ole, Lundgren, Jens, Mussini, C., Pedersen, C., De Wit, S., Kutsyna, G., Mocroft, A. & EuroSIDA in EuroCoord, E. I. E., 23 Oct 2016, In: AIDS. 30, 16, p. 2505-2518 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study

    Ryom, Lene, Lundgren, Jens, Ross, M., Kirk, Ole, Law, M., Morlat, P., Fontas, E., Smit, C., Fux, C. A., Hatleberg, C. I., De Wit, S., Sabin, C. A. & Mocroft, A., 15 Oct 2016, In: The Journal of Infectious Diseases. 214, 8, p. 1212-1220 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Infection-related and -unrelated malignancies, HIV and the aging population

    Shepherd, L., Borges, A. H. D., Ledergerber, B., Domingo, P., Castagna, A., Rockstroh, J., Knysz, B., Tomazic, J., Karpov, I., Kirk, Ole, Lundgren, Jens & Mocroft, A., Sep 2016, In: HIV Medicine. 17, 8, p. 590-600 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Associations between HIV-RNA-based indicators and virological and clinical outcomes

    Laut, K. G., Shepherd, L. C., Pedersen, C., Rockstroh, J. K., Sambatakou, H., Paduta, D., Matulionyte, R., Smiatacz, T., Mulcahy, F., Lundgren, Jens, Mocroft, A. & Kirk, Ole, 31 Jul 2016, In: AIDS (London, England). 30, 12, p. 1961-72 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?

    Boettiger, D. C., Sabin, C. A., Grulich, A., Ryom, Lene, Bonnet, F., Reiss, P., Monforte, A. D., Kirk, Ole, Phillips, A., Bower, M., Fätkenheuer, G., Lundgren, Jens, Law, M. & Data collection on Adverse events of Anti-HIV Drugs (D:A:D) study group, D. C. O. A. E. O. A. D. (. S. G., 19 Jun 2016, In: AIDS. 30, 10, p. 1629-37 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study

    Podlekareva, Daria, Efsen, A. M. W., Schultze, A., Post, F. A., Skrahina, A. M., Panteleev, A., Furrer, H., Miller, R. F., Losso, M. H., Toibaro, J., Miro, J. M., Vassilenko, A., Girardi, E., Bruyand, M., Obel, Niels, Lundgren, Jens, Mocroft, A., Kirk, Ole & TB:HIV study group in EuroCoord, T. S. G. I. E., Mar 2016, In: The Lancet HIV. 3, 3, p. e120-e131 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study

    Friis-Møller, N., Nielsen, L. R., Smith, C., Weber, R., Reiss, P., Dabis, F., De Wit, S., Monforte, A. D., Kirk, Ole, Fontas, E., Sabin, C., Phillips, A., Lundgren, Jens, Law, M. & D:A:D Study Group, D. S. G., Jan 2016, In: European Journal of Preventive Cardiology. 23, 2, p. 214-23 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1...3 4 5 6 7 8 9 10 ...17 Next

ID: 917608